PPARD and coronary artery disorder: Additionally, the GG genotype of PPARD rs3798343 decreased the risk of CAD by 39.4% (AOR, 95% CI: 0.606, 0.445–0.825; P*=0.001), and the GG+GA genotype decreased the risk of CAD by 38.3% (AOR, 95% CI: 0.617, 0.460–0.826; P*=0.001).